Acute Vertebrobasilar Occlusion
IV Abciximab, intra-arterial rtPA, and additional PTA/stenting improve outcome
Published in Clinical Trials Week, July 18th, 2005
"A combined therapy of local recombinant tissue plasminogen activator fibrinolysis and intravenous Abciximab platelet inhibition with additional percutaneous transluminal angioplasty/stenting may improve recanalization and neurological outcome in patients with acute vertebrobasilar occlusion. Combined FAST therapy consisted of intravenous bolus of Abciximab (0.25 mg/kg) followed by a 12-hour infusion therapy (0.125 mcg/kg per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-07-18)
More Articles from Clinical Trials Week
- Alzheimer Disease
A-beta immunization reduced cerebral volume in Alzheimer disease - Angiology
U.S. trial for atrial fibrillation underway - Anorexia Nervosa
Alendronate shows promise for treatment of osteopenia - Headache and Migraine
Almotriptan effective in patients with poor response to sumatriptan - Pain Management
Leading institution will study promise of a new antimicrobial benefit of ON-Q - Adrenalectomy
Transperitoneal and retroperitoneal approaches to adrenalectomy evaluated - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
